system, rendering it water soluble while targeting it for kidney removal to the urinary tract. Free, unmodified dietary resveratrol is typically less than 2 uM during its one and a half hour elevated blood plasma phase following ingestion. Glucuronate and sulfate derivatized resveratrol do not cross interstitial cell membranes and the low free resveratrol in cell microsomal fractions indicate that the interstitial cell extracellular sulfatases and glucuronidases have no general impact. This may not be true at sites of inflammation, but the desired whole body effect appears not to be there. Although we have no retention or turnover numbers on free intracellular resveratrol, it does not appear to accumulate over time. Experiments have shown that serum soluble free resveratrol concentration in the 20 uM range definitely impact the CR/AMPK pathway. For instance,
DMSO solubilized resveratrol, when injected into mice, causes all the desired AMPK and downstream effects in brain tissue.
As mentioned earlier, nutraceutical suppliers are being very ingenious in their attempts to get serum resveratrol concentrations up to the CR mimetic range. One supplier shows, graphically, how micronization of resveratrol dramatically increases free resveratrol up to and well beyond the minimal required AMPK activating range. Other suppliers are creating encapsulated, solubilized and time released formats. One supplier provides lozenges for sublingual delivery. Resveratrol mixed with synergizers such as quercetin and co enzyme Q, are also offered. We eagerly await their time based serum data, and even more so, their intracellular AMPK up regulation data.
Here’s a quick and dirty home remedy. You can dissolve